In conclusion, we showed that EGCG attenuated endoglin expression and myocardial fibrosis in vitro and in vivo, and that the novel suppressive effect was mediated through endoglin/JNK/AP‐1 pathway, which suggested the strong implications in controlling human cardiovascular diseases. This evidence concerns the gene ENG and cardiovascular disorder.